Cargando…
A prediction model for outcome in patients with HBV-ACLF based on predisposition, injury, response and organ failure
We aimed to develop a prediction model based on the PIRO concept (Predisposition, Injury, Response and Organ failure) for patients with Hepatitis B Virus (HBV) related acute-on-chronic liver failure (ACLF). 774 patients with HBV related ACLF defined in the CANONIC study were analyzed according to PI...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677318/ https://www.ncbi.nlm.nih.gov/pubmed/33214662 http://dx.doi.org/10.1038/s41598-020-77235-3 |
_version_ | 1783611945859940352 |
---|---|
author | Liu, Fangfang Zou, Zhengsheng Shen, Lijun Wu, Weiwei Luo, Jiajun Lankford, Seth Yang, Yongli Huang, Huang You, Shaoli Zhu, Bing Li, Jin Mu, Jinsong Zhang, Yawei Xin, Shaojie |
author_facet | Liu, Fangfang Zou, Zhengsheng Shen, Lijun Wu, Weiwei Luo, Jiajun Lankford, Seth Yang, Yongli Huang, Huang You, Shaoli Zhu, Bing Li, Jin Mu, Jinsong Zhang, Yawei Xin, Shaojie |
author_sort | Liu, Fangfang |
collection | PubMed |
description | We aimed to develop a prediction model based on the PIRO concept (Predisposition, Injury, Response and Organ failure) for patients with Hepatitis B Virus (HBV) related acute-on-chronic liver failure (ACLF). 774 patients with HBV related ACLF defined in the CANONIC study were analyzed according to PIRO components. Variables associated with mortality were selected into the prediction model. Based on the regression coefficients, a score for each PIRO component was developed, and a classification and regression tree was used to stratify patients into different nodes. The prediction model was then validated using an independent cohort (n = 155). Factors significantly associated with 90-day mortality were: P: age, gender and ACLF type; I: drug, infection, surgery, and variceal bleeding; R: systemic inflammatory response syndrome (SIRS), spontaneous bacteria peritonitis (SBP), and pneumonia; and O: the CLIF consortium organ failure score (CLIF-C OFs). The areas under the receiver operating characteristics curve (95% confidence interval) for the combined PIRO model for 90-day mortality were 0.77 (0.73–0.80). Based on the scores for each of the PIRO components and the cut-offs estimated from the classification and regression tree, patients were stratified into different nodes with different estimated death probability. Based on the PIRO concept, a new prediction model was developed for patients with HBV related ACLF, allowing stratification into different clusters using the different scores obtained in each PIRO component. The proposed model will likely help to stratify patients at different risk, defining individual management plans, assessing criteria for specific therapies, and predicting outcomes. |
format | Online Article Text |
id | pubmed-7677318 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-76773182020-11-23 A prediction model for outcome in patients with HBV-ACLF based on predisposition, injury, response and organ failure Liu, Fangfang Zou, Zhengsheng Shen, Lijun Wu, Weiwei Luo, Jiajun Lankford, Seth Yang, Yongli Huang, Huang You, Shaoli Zhu, Bing Li, Jin Mu, Jinsong Zhang, Yawei Xin, Shaojie Sci Rep Article We aimed to develop a prediction model based on the PIRO concept (Predisposition, Injury, Response and Organ failure) for patients with Hepatitis B Virus (HBV) related acute-on-chronic liver failure (ACLF). 774 patients with HBV related ACLF defined in the CANONIC study were analyzed according to PIRO components. Variables associated with mortality were selected into the prediction model. Based on the regression coefficients, a score for each PIRO component was developed, and a classification and regression tree was used to stratify patients into different nodes. The prediction model was then validated using an independent cohort (n = 155). Factors significantly associated with 90-day mortality were: P: age, gender and ACLF type; I: drug, infection, surgery, and variceal bleeding; R: systemic inflammatory response syndrome (SIRS), spontaneous bacteria peritonitis (SBP), and pneumonia; and O: the CLIF consortium organ failure score (CLIF-C OFs). The areas under the receiver operating characteristics curve (95% confidence interval) for the combined PIRO model for 90-day mortality were 0.77 (0.73–0.80). Based on the scores for each of the PIRO components and the cut-offs estimated from the classification and regression tree, patients were stratified into different nodes with different estimated death probability. Based on the PIRO concept, a new prediction model was developed for patients with HBV related ACLF, allowing stratification into different clusters using the different scores obtained in each PIRO component. The proposed model will likely help to stratify patients at different risk, defining individual management plans, assessing criteria for specific therapies, and predicting outcomes. Nature Publishing Group UK 2020-11-19 /pmc/articles/PMC7677318/ /pubmed/33214662 http://dx.doi.org/10.1038/s41598-020-77235-3 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Liu, Fangfang Zou, Zhengsheng Shen, Lijun Wu, Weiwei Luo, Jiajun Lankford, Seth Yang, Yongli Huang, Huang You, Shaoli Zhu, Bing Li, Jin Mu, Jinsong Zhang, Yawei Xin, Shaojie A prediction model for outcome in patients with HBV-ACLF based on predisposition, injury, response and organ failure |
title | A prediction model for outcome in patients with HBV-ACLF based on predisposition, injury, response and organ failure |
title_full | A prediction model for outcome in patients with HBV-ACLF based on predisposition, injury, response and organ failure |
title_fullStr | A prediction model for outcome in patients with HBV-ACLF based on predisposition, injury, response and organ failure |
title_full_unstemmed | A prediction model for outcome in patients with HBV-ACLF based on predisposition, injury, response and organ failure |
title_short | A prediction model for outcome in patients with HBV-ACLF based on predisposition, injury, response and organ failure |
title_sort | prediction model for outcome in patients with hbv-aclf based on predisposition, injury, response and organ failure |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677318/ https://www.ncbi.nlm.nih.gov/pubmed/33214662 http://dx.doi.org/10.1038/s41598-020-77235-3 |
work_keys_str_mv | AT liufangfang apredictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure AT zouzhengsheng apredictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure AT shenlijun apredictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure AT wuweiwei apredictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure AT luojiajun apredictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure AT lankfordseth apredictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure AT yangyongli apredictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure AT huanghuang apredictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure AT youshaoli apredictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure AT zhubing apredictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure AT lijin apredictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure AT mujinsong apredictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure AT zhangyawei apredictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure AT xinshaojie apredictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure AT liufangfang predictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure AT zouzhengsheng predictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure AT shenlijun predictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure AT wuweiwei predictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure AT luojiajun predictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure AT lankfordseth predictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure AT yangyongli predictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure AT huanghuang predictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure AT youshaoli predictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure AT zhubing predictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure AT lijin predictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure AT mujinsong predictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure AT zhangyawei predictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure AT xinshaojie predictionmodelforoutcomeinpatientswithhbvaclfbasedonpredispositioninjuryresponseandorganfailure |